NCT01628029 - Cognitive Behavioral Therapy and Multimodal Therapy in Treating Sleep Disturbance in Patients With Cancer | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

January 15, 2014

Primary Completion Date

December 31, 2025

Study Completion Date

December 31, 2025

Conditions

Hematopoietic and Lymphoid Cell NeoplasmMalignant Solid NeoplasmSleep Disorder

Interventions

OTHER

Counseling

Undergo CBT

DRUG

Methylphenidate Hydrochloride

Given PO

PROCEDURE

Phototherapy

Undergo light therapy

OTHER

Placebo Administration

Given PO

OTHER

Quality-of-Life Assessment

Ancillary studies

PROCEDURE

Sham Intervention

Undergo sham light therapy

DRUG

Therapeutic Melatonin

Given PO

Trial Locations (1)

M D Anderson Cancer Center, Houston

All Listed Sponsors

collaborator

National Cancer Institute (NCI)

NIH

lead

M.D. Anderson Cancer Center

OTHER